Orchid Pharma Reports Positive EBIDTA, In Q2′ 2022
1 min read Post a successful turnaround of IBC case, the company continues its march towards growth and sustainability NEW DELHI, Nov. 16, 2022 /PRNewswire/ -- Orchid Pharma today announced their Q2'22 results. Fuelled by increasing sales and a laser sharp focus
Post a successful turnaround of IBC case, the company continues its march towards growth and sustainability NEW DELHI, Nov. 16, 2022 /PRNewswire/ — Orchid Pharma today announced their Q2’22 results. Fuelled by increasing sales and a laser sharp focusPost a successful turnaround of IBC case, the company continues its march towards growth and sustainability NEW DELHI, Nov. 16, 2022 /PRNewswire/ — Orchid Pharma today announced their Q2’22 results. Fuelled by increasing sales and a laser sharp focus
About Author
